REFERENCES
1. Defaye B, Moutailler S, Pasqualini V, Quilichini Y. A Systematic Review of the Distribution of Tick-Borne Pathogens in Wild Animals and Their Ticks in the Mediterranean Rim between 2000 and 2021.Microorganisms 2022;10(9):1858.
2. Lee W, Barbosa AD, Irwin PJ, Currie A, Kollmann TR, Beaman M, et al. A systems biology approach to better understand human tick-borne diseases. Trends Parasitol . 2023;39(1):53–69.
3. Anisuzzaman, Islam MK, Alim MA, Miyoshi T, Hatta T, Yamaji K, et al. Longistatin, a Plasminogen Activator, Is Key to the Availability of Blood-Meals for Ixodid Ticks. Vernick KD, editor. PLoS Pathog . 2011;7(3):e1001312.
4. Déruaz M, Frauenschuh A, Alessandri AL, Dias JM, Coelho FM, Russo RC, et al. Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J Exp Med . 2008;205(9):2019–31.
5. Anisuzzaman, Anas A, Yasin MG, Labony SS, Hossain MM, Begum N, et al. Natural nodular worm infection in goats induces eosinophil extracellular DNA trap (EET) formation. Parasitol Int. 2020;79:102178.
6. Anisuzzaman A, Hatta T, Miyoshi T, Matsubayashi M, Islam MK, Alim MA, et al. Longistatin in tick saliva blocks advanced glycation end-product receptor activation. J Clin Invest. 2014;124(10):4429–44.
7. van Zoelen MAD, Achouiti A, van der Poll T. The role of receptor for advanced glycation endproducts (RAGE) in infection. Crit Care . 2011;15(2):208.
8. Lange-Sperandio B, Sperandio M, Nawroth P, Bierhaus A. RAGE Signaling in Cell Adhesion and Inflammation. Curr Pediatr Rev . 2007;3(1):1–9.
9. Hovius JWR, Levi M, Fikrig E. Salivating for Knowledge: Potential Pharmacological Agents in Tick Saliva. PLOS Med . 2008;5(2):e43.
10. Karasuyama H, Miyake K, Yoshikawa S. Immunobiology of Acquired Resistance to Ticks. Front Immunol . 2020;11:2732.
11. Hatta T, Tsuji N, Miyoshi T, Islam MK, Alim MA, Yamaji K, et al. Leucine aminopeptidase, HlLAP, from the ixodid tick Haemaphysalis longicornis, plays vital roles in the development of oocytes.Parasitol Int . 2010;59(2):286–9.
12. Myint KM, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H, et al. RAGE Control of Diabetic Nephropathy in a Mouse Model. Diabetes . 2006;55(9):2510–22.
13. Luna LG. Manual of histologic staining methods of the Armed Forces Institute of Pathology. 3rd ed. New York, USA: Blakiston Division, McGraw-Hill; 1968. 258 p.
14. Wada T, Ishiwata K, Koseki H, Ishikura T, Ugajin T, Ohnuma N, et al. Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks. J Clin Invest . 2010;120(8):2867–75.
15. Imai Y. ILC2s in skin disorders. Allergol Int . 2023;72(2):201–6.
16. Marco Manfredini and, Borgia F, Li Pomi F, Alessandrello C, Vaccaro M, Gangemi S. Potential Role of Innate Lymphoid Cells in the Pathogenesis and Treatment of Skin Diseases. J Clin Med . 2023;12(8):3043.
17. Štibrániová I, Bartíková P, Holíková V, Kazimírová M. Deciphering Biological Processes at the Tick-Host Interface Opens New Strategies for Treatment of Human Diseases. Front Physiol . 2019;10:830.
18. Miyagawa T, Iwata Y, Oshima M, Ogura H, Sato K, Nakagawa S, et al. Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury. Biol Open . 2022;11(1).
19. Ota C, Ishizawa K, Yamada M, Tando Y, He M, Takahashi T, et al. Receptor for advanced glycation end products expressed on alveolar epithelial cells is the main target for hyperoxia-induced lung injury.Respir Investig . 2016;54(2):98–108.
20. Iwamura M, Yamamoto Y, Kitayama Y, Higuchi K, Fujimura T, Hase T, et al. Epidermal expression of receptor for advanced glycation end products (RAGE) is related to inflammation and apoptosis in human skin. Exp Dermatol . 2016;25(3):235–7.
21. Anisuzzaman, Islam MK, Alim MA, Miyoshi T, Hatta T, Yamaji K, et al. Longistatin is an unconventional serine protease and induces protective immunity against tick infestation. Mol Biochem Parasitol.2012;182(1–2):45–53.
22. Curran CS, Bertics PJ. Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B. Int Immunol. 2011;23(12):713–28.
23. Salem SAM, El-Khateeb EA, Harvy M, Emam HMES, Abdelaal W, Nemr R El, et al. Study of serum levels and skin expression of S100B protein in psoriasis. An Bras Dermatol . 2017;92:323–8.
24. Chen B, Miller AL, Rebelatto M, Brewah Y, Rowe DC, Clarke L, et al. S100A9 Induced Inflammatory Responses Are Mediated by Distinct Damage Associated Molecular Patterns (DAMP) Receptors In Vitro andIn Vivo . PLoS One . 2015 2023;10(2):e0115828.
25. Dyer KD, Rosenberg HF. Physiologic Concentrations of HMGB1 Have No Impact on Cytokine-Mediated Eosinophil Survival or Chemotaxis in Response to Eotaxin-2 (CCL24). PLoS One . 2015;10(3):e0118887.
26. Zhang K, Jin Y, Lai D, Wang J, Wang Y, Wu X, et al. RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock. Thorax [Internet]. 2020;75(3):209–19.
27. Roediger B, Kyle R, Yip KH, Sumaria N, Guy T V., Kim BS, et al. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat Immunol. 2013;14(6):564–73.
28. Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF, et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med . 2013;5(170).
29. Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate Lymphoid Cells: 10 Years On. Cell.2018;174(5):1054–66.
30. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TKA, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature . 2010;464(7293):1367–70.
31. Löser S, Smith KA, Maizels RM. Innate lymphoid cells in helminth infections—obligatory or accessory? Front Immunol . 2019 Apr 10;10:620.
32. Panda SK, Colonna M. Innate lymphoid cells in mucosal immunity.Front Immunol . 2019;10:861.
33. Ebbo M, Crinier A, Vély F, Vivier E. Innate lymphoid cells: major players in inflammatory diseases. Nat Rev Immunol . 2017;17(11):665–78.
34. Dyer KD, Rosenberg HF. Physiologic Concentrations of HMGB1 Have No Impact on Cytokine-Mediated Eosinophil Survival or Chemotaxis in Response to Eotaxin-2 (CCL24). PLoS One . 2015;10(3):e0118887.
35. Kvarnhammar AM, Cardell LO. Pattern-recognition receptors in human eosinophils. Immunology . 2012;136(1):11–20.